129 related articles for article (PubMed ID: 34624928)
1. Type I interferon supports γδ T-cell homeostasis and immunity through direct and indirect receptor signaling in mice.
Agerholm R; Kadekar D; Rizk J; Bekiaris V
Eur J Immunol; 2021 Dec; 51(12):3186-3193. PubMed ID: 34624928
[TBL] [Abstract][Full Text] [Related]
2. Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections.
Henry T; Kirimanjeswara GS; Ruby T; Jones JW; Peng K; Perret M; Ho L; Sauer JD; Iwakura Y; Metzger DW; Monack DM
J Immunol; 2010 Apr; 184(7):3755-67. PubMed ID: 20176744
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.
Yang Q; Stevenson HL; Scott MJ; Ismail N
Am J Pathol; 2015 Feb; 185(2):446-61. PubMed ID: 25481711
[TBL] [Abstract][Full Text] [Related]
4. IL-1β and IL-23 Promote Extrathymic Commitment of CD27
Muschaweckh A; Petermann F; Korn T
J Immunol; 2017 Oct; 199(8):2668-2679. PubMed ID: 28855314
[TBL] [Abstract][Full Text] [Related]
5. The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.
Kadekar D; Agerholm R; Rizk J; Neubauer HA; Suske T; Maurer B; Viñals MT; Comelli EM; Taibi A; Moriggl R; Bekiaris V
J Clin Invest; 2020 May; 130(5):2496-2508. PubMed ID: 32281944
[TBL] [Abstract][Full Text] [Related]
6. Type I IFN Receptor Signaling Controls IL7-Dependent Accumulation and Activity of Protumoral IL17A-Producing γδT Cells in Breast Cancer.
Patin EC; Soulard D; Fleury S; Hassane M; Dombrowicz D; Faveeuw C; Trottein F; Paget C
Cancer Res; 2018 Jan; 78(1):195-204. PubMed ID: 29070614
[TBL] [Abstract][Full Text] [Related]
7. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon is selectively required by dendritic cells for immune rejection of tumors.
Diamond MS; Kinder M; Matsushita H; Mashayekhi M; Dunn GP; Archambault JM; Lee H; Arthur CD; White JM; Kalinke U; Murphy KM; Schreiber RD
J Exp Med; 2011 Sep; 208(10):1989-2003. PubMed ID: 21930769
[TBL] [Abstract][Full Text] [Related]
9. IL-18R signaling is required for γδ T cell response and confers resistance to Trypanosoma cruzi infection.
da Mota JB; Echevarria-Lima J; Kyle-Cezar F; Melo M; Bellio M; Scharfstein J; Oliveira AC
J Leukoc Biol; 2020 Oct; 108(4):1239-1251. PubMed ID: 32450614
[TBL] [Abstract][Full Text] [Related]
10. The immune checkpoint receptor associated phosphatases SHP-1 and SHP-2 are not required for γδT17 cell development, activation, or skin inflammation.
Kadekar D; Agerholm R; Viñals MT; Rizk J; Bekiaris V
Eur J Immunol; 2020 Jun; 50(6):873-879. PubMed ID: 32092146
[TBL] [Abstract][Full Text] [Related]
11. IL-17-producing γδ T cells switch migratory patterns between resting and activated states.
McKenzie DR; Kara EE; Bastow CR; Tyllis TS; Fenix KA; Gregor CE; Wilson JJ; Babb R; Paton JC; Kallies A; Nutt SL; Brüstle A; Mack M; Comerford I; McColl SR
Nat Commun; 2017 Jun; 8():15632. PubMed ID: 28580944
[TBL] [Abstract][Full Text] [Related]
12. Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes.
Lu C; Klement JD; Ibrahim ML; Xiao W; Redd PS; Nayak-Kapoor A; Zhou G; Liu K
J Immunother Cancer; 2019 Jun; 7(1):157. PubMed ID: 31228946
[TBL] [Abstract][Full Text] [Related]
13. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
14. Th17 cells are not required for maintenance of IL-17A-producing γδ T cells in vivo.
Gupta PK; Wagner SR; Wu Q; Shilling RA
Immunol Cell Biol; 2017 Mar; 95(3):280-286. PubMed ID: 27649780
[TBL] [Abstract][Full Text] [Related]
15. γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program.
Muro R; Nitta T; Nakano K; Okamura T; Takayanagi H; Suzuki H
J Clin Invest; 2018 Jan; 128(1):415-426. PubMed ID: 29202478
[TBL] [Abstract][Full Text] [Related]
16. Adipose type I interferon signalling protects against metabolic dysfunction.
Wieser V; Adolph TE; Grander C; Grabherr F; Enrich B; Moser P; Moschen AR; Kaser S; Tilg H
Gut; 2018 Jan; 67(1):157-165. PubMed ID: 28011892
[TBL] [Abstract][Full Text] [Related]
17. Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans.
Chen X; Cai Y; Hu X; Ding C; He L; Zhang X; Chen F; Yan J
Sci Adv; 2022 May; 8(21):eabm9120. PubMed ID: 35613277
[TBL] [Abstract][Full Text] [Related]
18. Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.
Jennings RN; Grayson JM; Barton ES
J Virol; 2014 Dec; 88(24):14040-9. PubMed ID: 25253356
[TBL] [Abstract][Full Text] [Related]
19. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus.
Tsai CY; Liong KH; Gunalan MG; Li N; Lim DS; Fisher DA; MacAry PA; Leo YS; Wong SC; Puan KJ; Wong SB
J Immunol; 2015 Apr; 194(8):3890-900. PubMed ID: 25732728
[TBL] [Abstract][Full Text] [Related]
20. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
